Xilio Therapeutics (XLO) Revenue

219 Followers

Statistics Market Cap Revenue

Xilio Therapeutics Revenue

Xilio Therapeutics had a revenue of 12.65M in the quarter ending Mar 31, 2026, with -7.58%. This bring the company's revenue in the last twelve months to 53.48M, Decreased 22.20%. In the fiscal year ending Dec 31, 2025, Xilio Therapeutics had annual revenue of 43.77M with 589.88% growth.

Revenue (ttm)

53.48M

Revenue Growth

476.71%

P/S Ratio

1.15

Revenue/Employee

$683,844

Employees

Market Cap

$50.50M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	43.77M	37.42M	+589.88%
Dec 31, 2024	6.34M	―	+∞%
Dec 31, 2023	―	―	―
Dec 31, 2022	―	―	―
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―